Aya Shiba-Ishii

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Topics

Advanced Non Small Cell Lung Cancer

Chronic Myeloid Leukemia

Top Venues

Pathology international

This page only lists publications with an associated author ORCID identifier.

Publications

Aya Shiba-Ishii, Noriko Takemura, Hitomi Kawai, Daisuke Matsubara
Histologic transformation of non-small-cell lung cancer in response to tyrosine kinase inhibitors: Current knowledge of genetic changes and molecular mechanisms. Cancer science 115 (7) (2024)
Aya Shiba-Ishii, Noriko Takemura, Hitomi Kawai, Daisuke Matsubara
Histologic transformation of non-small-cell lung cancer in response to tyrosine kinase inhibitors: Current knowledge of genetic changes and molecular mechanisms. Cancer science 115 (7) (2024)
Aya Shiba-Ishii, Noriko Takemura, Hitomi Kawai, Daisuke Matsubara
Histologic transformation of non-small-cell lung cancer in response to tyrosine kinase inhibitors: Current knowledge of genetic changes and molecular mechanisms. Cancer science 115 (7) (2024)
Aya Shiba-Ishii, Noriko Takemura, Hitomi Kawai, Daisuke Matsubara
Histologic transformation of non-small-cell lung cancer in response to tyrosine kinase inhibitors: Current knowledge of genetic changes and molecular mechanisms. Cancer science 115 (7) (2024)
Aya Shiba-Ishii, Noriko Takemura, Hitomi Kawai, Daisuke Matsubara
Histologic transformation of non-small-cell lung cancer in response to tyrosine kinase inhibitors: Current knowledge of genetic changes and molecular mechanisms. Cancer science (2024)
Fumiya Teruyama, Akihiro Kuno, Yoshihiko Murata, Tomoki Nakagawa, Aya Shiba-Ishii, Shu Yuguchi, Masayuki Noguchi
Mutational landscape of primary breast angiosarcoma with repeated resection and recurrence over a 15-year period: A case report. Pathology international 72 (9) (2022)
Jeongmin Hong, Aya Shiba-Ishii, Yunjung Kim, Masayuki Noguchi, Noriaki Sakamoto
Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma. Cancer science 112 (12) (2021)
Aya Shiba-Ishii
Significance of stratifin in early progression of lung adenocarcinoma and its potential therapeutic relevance. Pathology international 71 (10) (2021)
Yunjung Kim, Aya Shiba-Ishii, Karina Ramirez, Masafumi Muratani, Noriaki Sakamoto, Tatsuo Iijima, Masayuki Noguchi
Carcinogen-induced tumors in SFN-transgenic mice harbor a characteristic mutation spectrum of human lung adenocarcinoma. Cancer science 110 (8) (2019)
Yunjung Kim, Aya Shiba-Ishii, Tomoki Nakagawa, Shun-Ichiro Iemura, Tohru Natsume, Noriyuki Nakano, Ryota Matsuoka, Shingo Sakashita, SangJoon Lee, Atsushi Kawaguchi, Yukio Sato, Masayuki Noguchi
Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma. Oncogene 37 (40) (2018)
Mai Sakashita, Shingo Sakashita, Yoshihiko Murata, Aya Shiba-Ishii, Yunjung Kim, Ryota Matsuoka, Noriyuki Nakano, Yukio Sato, Masayuki Noguchi
High expression of ovarian cancer immunoreactive antigen domain containing 2 (OCIAD2) is associated with poor prognosis in lung adenocarcinoma. Pathology international 68 (11) (2018)
Yunjung Kim, Aya Shiba-Ishii, Tomoki Nakagawa, Ryan Edbert Husni, Shingo Sakashita, Tomoyo Takeuchi, Masayuki Noguchi
Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma. Pathology international 67 (6) (2017)